Black race independently predicts worse survival in uterine carcinosarcoma

被引:25
作者
Erickson, Britt K. [1 ]
Doo, David W. [2 ]
Zhang, Bin [3 ]
Huh, Warner K. [1 ]
Leath, Charles A., III [1 ]
机构
[1] Univ Alabama, Div Gynecol Oncol, Tuscaloosa, AL 35487 USA
[2] Univ Colorado, Dept Obstet & Gynecol, Boulder, CO 80309 USA
[3] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA
关键词
Uterine carcinosarcoma; Racial disparities; Adjuvant treatment; EPITHELIAL OVARIAN-CANCER; PHASE-III TRIAL; STAGE-I; RACIAL DISPARITIES; IFOSFAMIDE; CISPLATIN; THERAPY; TUMORS;
D O I
10.1016/j.ygyno.2014.02.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. COG 150 suggested that Black women had worse survival compared to White women with uterine carcinosarcoma. Our objective was to compare treatment and survival outcomes between Black and White women at a National Comprehensive Cancer Network (NCCN) cancer center serving a diverse racial population. Methods. An IRB approved retrospective cohort study of uterine carcinosarcoma patients diagnosed between 2000 and 2012 was performed. Survival was compared by race and stratified by stage. Median progression free and overall survival (PFS and OS) were calculated using Kaplan-Meier estimates and compared with the log-rank test. Multivariate survival analysis was performed with Cox proportional hazards model. Results. 158 women were included: 93 (59%) were Black and 65 (41%) were White. 95(60%) had early stage disease and 63 (40%) had advanced stage disease. Black women had a shorter PFS (7.9 vs. 14.2 months, p < 0.001) and OS (13.4 vs. 30.8 months, p < 0.001). There was no difference in survival between Black and White women with advanced stage disease (OS 8.5 vs. 11.8, p = 0.18). However, PFS and OS were worse in Black women compared to White women with early stage disease (PFS 13.6 vs. 77.4, p = 0.001), (OS 25.4 vs. 94.7, p = 0.003). On multivariate analysis accounting for age, stage, BMI, and adjuvant treatment, Black race remained independently associated with risk of death (HR 2.0; 95% CI 1.25-3.23). Conclusions. Black women with uterine carcinosarcoma have worse survival compared to White women despite similar patient and treatment characteristics. This difference is largely due to differences in survival in early stage disease. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:238 / 241
页数:4
相关论文
共 19 条
[1]  
American Cancer Society, 2012, CANC FACTS FIGS 2012
[2]   Ethnic differences in survival among women with ovarian carcinoma [J].
Barnholtz-Sloan, JS ;
Tainsky, MA ;
Abrams, J ;
Severson, RK ;
Qureshi, F ;
Jacques, SM ;
Levin, N ;
Schwartz, AG .
CANCER, 2002, 94 (06) :1886-1893
[3]   Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status [J].
Bristow, Robert E. ;
Powell, Matthew A. ;
Al-Hammadi, Noor ;
Chen, Ling ;
Miller, J. Philip ;
Roland, Phillip Y. ;
Mutch, David G. ;
Cliby, William A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (11) :823-832
[4]   Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States [J].
Chan, John K. ;
Zhang, Mallory ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (02) :103-107
[5]   Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study [J].
Homesley, Howard D. ;
Filiaci, Virginia ;
Markman, Maurie ;
Bitterman, Pincas ;
Eaton, Lynne ;
Kilgore, Larry C. ;
Monk, Bradley J. ;
Ueland, Frederick R. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :526-531
[6]   Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: A fundamental cause of disease approach [J].
Kim, Seijeoung ;
Dolecek, Therese A. ;
Davis, Faith G. .
SOCIAL SCIENCE & MEDICINE, 2010, 71 (02) :274-281
[7]   Patterns of Failure for Conservatively Managed Surgical Stage I Uterine Carcinosarcoma Implications for Adjuvant Therapy [J].
Leath, Charles A., III ;
Numnum, T. Michael ;
Kendrick, James E. ;
Frederick, Peter J. ;
Rocconi, Rodney P. ;
Conner, Michael G. ;
Straughn, J. Michael, Jr. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) :888-891
[8]   PROGNOSTIC FACTORS IN EARLY-STAGE UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
MAJOR, FJ ;
BLESSING, JA ;
SILVERBERG, SG ;
MORROW, CP ;
CREASMAN, WT ;
CURRIE, JL ;
YORDAN, E ;
BRADY, MF .
CANCER, 1993, 71 (04) :1702-1709
[9]   Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas [J].
McCluggage, WG .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) :687-690
[10]  
Mutch DG., 2009, Gynecol Oncol, V115, P325